Burning Rock Biotech Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Burning Rock Biotech Limited (BNR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $18.71 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-04-28
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $18.71M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.24M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.44M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $19.28M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $18.71M 20-F · filed 2026-04-28 |
| 2024-12-31 | $4.24M 20-F · filed 2026-04-28 |
| 2023-12-31 | $10.44M 20-F · filed 2025-04-29 |
| 2022-12-31 | $19.28M 20-F · filed 2024-04-29 |
| 2021-12-31 | $69.91M 20-F · filed 2023-04-20 |
| 2020-12-31 | $176.96M 20-F · filed 2023-04-20 |
| 2019-12-31 | $20.08M 20-F · filed 2023-04-20 |
| 2018-12-31 | $9.74M 20-F · filed 2022-04-29 |
| 2017-12-31 | $6.74M 20-F · filed 2021-03-23 |